Dr. Morten focuses on patent matters. He has experience in district court litigation, including Hatch-Waxman (ANDA) litigation, as well as trials at the Patent Trial and Appeal Board (PTAB), patent prosecution, and patent strategy and counseling. He has worked on numerous matters in diverse fields, including biotechnology, pharmaceuticals, polymers, food science, consumer products, fragrance chemistry, agricultural products, and petrochemistry.
Representative matters include:
- ApoPharma Inc. v. Taro Pharmaceutical Industries, Ltd., No. 2:16-cv-528 (E.D. Tex.): Representing defendant Taro in ongoing Hatch-Waxman patent litigation involving ApoPharma’s FERRIPROX® (deferiprone) product.
- Lupin Atlantis Holdings, S.A. v. InvaGen Pharmaceuticals, Inc., No. 16-708 (D. Del.): Representing plaintiff Lupin in ongoing Hatch-Waxman patent litigation involving Lupin’s ANTARA® (fenofibrate) product.
- Tris Pharma, Inc. v. Actavis Elizabeth LLC, No. 16-603 (D. Del.): Representing defendant Actavis in ongoing Hatch-Waxman patent litigation involving Tris’s QUILLICHEW ER® (methylphenidate) product.
- Successful IPR challenges to patents covering injectable iron complexes for treatment of iron deficiency anemia.
Dr. Morten is a member of the New York Intellectual Property Law Association (NYIPLA).
Prior to rejoining Goodwin in 2016, Dr. Morten clerked for Judge Timothy B. Dyk of the U.S. Court of Appeals for the Federal Circuit.
From 2014 to 2015, Dr. Morten worked as a scientific advisor and patent agent at another law firm, focusing on patent prosecution and counseling for life sciences, chemical, and consumer products clients. From 2011 to 2013, he was a science advisor at Goodwin, advising on patent litigation, patent opinion, and due diligence matters for pharmaceutical and biotechnology clients.
Dr. Morten’s graduate research explored the biosynthesis, total synthesis and chemical biology of ladder polyether toxins, a class of biologically active polyketide molecules implicated in many red tide outbreaks. In 2010, he received a Roche Excellence in Chemistry Award for research in organic chemistry.